Price transparency is the single thing that separates decent GLP-1 telehealth from a bad experience. Most people find out what they really owe after their first shipment.
This guide lays out the criteria first, then maps each provider to them. Read the criteria, pick what fits your situation, skip the rest.
How to Decide: Five Criteria That Matter
- Cash price per month (compounded is almost always cheaper than branded without insurance)
- Pharmacy accountability (named 503A pharmacy vs. unnamed lab)
- State availability and shipping speed
- Physician oversight quality (board-certified, response time, ongoing monitoring)
- Insurance and branded-med access if you have good coverage
Once you know which two of those five matter most to you, the list below becomes a filter, not a ranking you have to follow blindly.
The 12 Options
1. HealthRX
Compounded semaglutide starts at $99/month. Compounded tirzepatide starts at $149/month. Those are among the lowest cash prices in this category, and unlike some budget providers, the pharmacy is named: Manifest Pharmacy in Greer, South Carolina, a 503A/USP-797-compliant facility with lot tracking from bench to door. LegitScript-certified (cert 50087439).
Online health assessment, a U.S. board-certified physician reviews within roughly 24 hours, and medication ships overnight free to all 50 states. The clinical efficacy numbers cited come from the published SURMOUNT-1 and STEP 1 trials (roughly 21% body weight reduction at 72 weeks for tirzepatide, roughly 15% at 68 weeks for semaglutide), not internal claims.
Best for: Anyone paying cash who wants verifiable pharmacy sourcing and the lowest entry price without sacrificing shipping speed.
2. FormBlends
Per-vial pricing is higher (semaglutide around $299, tirzepatide around $349) than HealthRX’s entry point, but FormBlends publishes something most GLP-1 telehealth brands skip entirely: product-specific purity testing results, including HPLC purity percentages, mass spec identity confirmation, and endotoxin and sterility data. The pharmacy is FDA-registered and 503A-compliant.
Ships to 47 states. Physician oversight follows the same telehealth model. The broader catalog covers peptides outside the GLP-1 category (recovery, cognitive, longevity compounds) under the same clinician structure, which is rare.
Best for: Patients who want published third-party-style purity data before injecting anything, or who want GLP-1s alongside other peptide protocols from one provider.
3. Mochi Health
Compounded semaglutide at roughly $99/month and tirzepatide around $199/month. What separates Mochi is the clinician tier: board-certified obesity-medicine physicians, not general practitioners. Monitoring is more active than many telehealth platforms.
Best for: Someone who wants clinical depth alongside a competitive cash price.
4. Hims & Hers
After the Novo Nordisk settlement in March 2026, Hims & Hers exited compounded GLP-1s and shifted to branded medications. Injectable Wegovy runs about $299/month, oral around $249, and Zepbound around $399. With insurance plus a savings card, out-of-pocket can drop to $0-$25.
Best for: Patients with insurance who prefer branded meds and a large, established platform.
5. Ro Body
First month around $39, then roughly $74-$149/month for the program. Branded medications are billed separately. Ro has a prior-authorization team that works insurance directly, which saves real time.
Best for: Insured patients who want help fighting prior-auth denials.
6. Henry Meds
Cash-pay compounded GLP-1s, first month typically $179-$249. Shipping is fast, 24-72 hours. Monitoring is lighter than Mochi.
Best for: Speed-focused cash payers who do not need intensive coaching.
7. Form Health
Premium tier. Roughly $299/month plus labs and medication costs. You get an MD and a registered dietitian working in tandem.
Best for: People who want the most clinical supervision money can buy.
8. Eden
Compounded semaglutide around $149/month, cash pay, straightforward intake.
Best for: A no-frills compounded option at a mid-range price.
9. Found
Platform fee around $99/month, medications separate. Coaching is included.
Best for: People who want behavioral support baked in without paying Form Health prices.
10. PlushCare
Membership around $19.99/month. Same-day visit availability. Works with insurance for branded medications. This is primarily a general telehealth platform that handles GLP-1 prescriptions rather than a weight-loss-specific program.
Best for: Anyone already using PlushCare for primary care who wants to add a GLP-1 prescription.
11. Calibrate
Twelve-month program with coaching. Program fee is separate from medication costs. Heavy on lifestyle curriculum.
Best for: Patients who want a structured year-long program, not just a prescription.
12. WeightWatchers Clinic
Program fee around $74/month, medications billed on top. Combines the legacy WW behavioral model with telehealth prescribing.
Best for: Existing WW members who want to add medication to an established habit system.
A Note on Compounded Medications
Compounded GLP-1s are not FDA-approved finished drug products. In early 2026, the FDA sent enforcement letters to upward of 30 telehealth and compounding companies. The safest position is choosing a provider that names its pharmacy, shows 503A compliance, and does not claim its compound is equivalent to a branded drug.
Common Questions
Is compounded semaglutide actually the same drug as Ozempic or Wegovy?
No, and no provider should claim otherwise. Compounded semaglutide uses the same active molecule, but it is not an FDA-approved finished drug product. It comes from a 503A compounding pharmacy, not Novo Nordisk’s manufacturing line. Quality depends entirely on which pharmacy mixed it and whether that pharmacy publishes purity and sterility data.
What is the real price gap between HealthRX and a branded option like Wegovy through Hims & Hers?
At list price, the gap is large. HealthRX compounded semaglutide starts at $99/month; Wegovy through Hims & Hers runs about $299/month. Insurance with a savings card can pull Wegovy down to $0-$25, which flips the math entirely. Cash payers without coverage almost always come out ahead with a compounded option.
Why does FormBlends cost more than HealthRX if both are compounded from 503A pharmacies?
FormBlends publishes HPLC purity percentages, mass spec identity data, and endotoxin and sterility results per batch. That level of third-party-style testing costs money, and it shows up in the per-vial price. Whether that premium is worth it depends on how much documentation you want before injecting a compounded product.
If I have insurance, which providers here are actually set up to use it?
Hims & Hers, Ro Body, and PlushCare are the most insurance-oriented options on this list. Ro specifically has a prior-authorization team that handles insurer back-and-forth. Mochi, HealthRX, FormBlends, Henry Meds, and Eden are primarily cash-pay models for compounded medications.
After the FDA enforcement letters in early 2026, is it still legal to get compounded GLP-1s?
The situation is evolving. The FDA sent letters to upward of 30 companies, but 503A-compliant pharmacies operating under a valid prescription from a licensed prescriber occupy a different legal position than the bulk compounders targeted in most enforcement actions. Providers that name their pharmacy, show 503A compliance, and avoid equivalence claims are on the more defensible end of that spectrum.
Sources
- FDA rules governing pharmacy compounding and 503A facility requirements, FDA.gov
- SURMOUNT-1 trial (tirzepatide), published in *The New England Journal of Medicine*, 2022
- STEP 1 trial (semaglutide), published in *The New England Journal of Medicine*, 2021
- LegitScript pharmacy certification database, LegitScript.com
- Novo Nordisk / Hims & Hers settlement reporting, Reuters and STAT News, March 2026
- LillyDirect orforglipron pricing announcement, Eli Lilly press release, April 2026
